skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 6
Patent #:
10513497
Issue Dt:
12/24/2019
Application #:
15932327
Filing Dt:
02/16/2018
Publication #:
20180237396
Pub Dt:
08/23/2018
Inventors:
Pooran Chand, Yogesh Kumar Gupta, Rakesh Kumar Kumawat, Mamoun Alhamadsheh et al
Title:
Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
Assignment: 1
Reel/Frame:
048671/0933Recorded: 03/22/2019Pages: 10
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
CHAND, POORAN
Exec Dt:
10/11/2018
GUPTA, YOGESH KUMAR
Exec Dt:
10/11/2018
KUMAWAT, RAKESH KUMAR
Exec Dt:
10/11/2018
ALHAMADSHEH, MAMOUN
Exec Dt:
10/11/2018
ZAMBONI, ROBERT
Exec Dt:
03/22/2019
Assignee:
EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, 25TH FLOOR
SAN FRANCISCO, CALIFORNIA 94104
Correspondent:
MINTZ LEVIN/SAN FRANCISCO OFFICE
ONE FINANCIAL CENTER
BOSTON, MA 02111
Assignment: 2
Reel/Frame:
058144/0302Recorded: 11/17/2021Pages: 12
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BRIDGEBIO PHARMA, INC.
Exec Dt:
11/17/2021
ORIGIN BIOSCIENCES, INC.
Exec Dt:
11/17/2021
EIDOS THERAPEUTICS, INC.
Exec Dt:
11/17/2021
QED THERAPEUTICS, INC.
Exec Dt:
11/17/2021
ADRENAS THERAPEUTICS, INC.
Exec Dt:
11/17/2021
PHOENIX TISSUE REPAIR, INC.
Exec Dt:
11/17/2021
Assignee:
U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
GLOBAL CORPORATE TRUST
1 FEDERAL ST.
BOSTON, MASSACHUSETTS 02110
Correspondent:
PILLSBURY WINTHROP SHAW PITTMAN LLP
12255 EL CAMINO REAL
SUITE 300
SAN DIEGO, CA 92130-4088
Assignment: 3
Reel/Frame:
066155/0019Recorded: 01/17/2024Pages: 9
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
EIDOS THERAPEUTICS, INC.
Exec Dt:
01/17/2024
Assignee:
ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
225 WEST WASHINGTON STREET, 9TH FLOOR
CHICAGO, ILLINOIS 60606
Correspondent:
COOLEY LLP
3 EMBARCADERO CENTER, 20TH FLOOR
SAN FRANCISCO, CA 94111
Assignment: 4
Reel/Frame:
066167/0462Recorded: 01/18/2024Pages: 9
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignor:
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Exec Dt:
01/17/2024
Assignees:
BRIDGEBIO PHARMA, INC.
3160 PORTER DRIVE, SUITE 250
PALO ALTO, CALIFORNIA 94304
ORIGIN BIOSCIENCES, INC.
3160 PORTER DRIVE, SUITE 250
PALO ALTO, CALIFORNIA 94304
EIDOS THERAPEUTICS, INC.
1800 OWENS ST., SUITE C-1100
SAN FRANCISCO, CALIFORNIA 94158
QED THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250
PALO ALTO, CALIFORNIA 94304
ADRENAS THERAPEUTICS, INC.
1001 WILLIAM MOORE DRIVE, STE 100
RALEIGH, NORTH CAROLINA 27606
PHOENIX TISSUE REPAIR, INC.
3160 PORTER DRIVE, SUITE 250
PALO ALTO, CALIFORNIA 94304
Correspondent:
COOLEY LLP
3 EMBARCADERO CENTER, 20TH FLOOR
SAN FRANCISCO, CA 94111
Assignment: 5
Reel/Frame:
066342/0154Recorded: 01/17/2024Pages: 26
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
CALCILYTIX THERAPEUTICS INC.
Exec Dt:
01/17/2024
ADRENAS THERAPEUTICS INC.
Exec Dt:
01/17/2024
PHOENIX TISSUE REPAIR, INC.
Exec Dt:
01/17/2024
NAVIRE PHARMA, INC.
Exec Dt:
01/17/2024
VENTHERA, INC.
Exec Dt:
01/17/2024
MOLECULAR SKIN THERAPEUTICS, INC.
Exec Dt:
01/17/2024
CANTERO THERAPEUTICS, INC.
Exec Dt:
01/17/2024
COA THERAPEUTICS, INC.
Exec Dt:
01/17/2024
PORTAL THERAPEUTICS, INC.
Exec Dt:
01/17/2024
BRIDGEBIO GENE THERAPY RESEARCH, INC.
Exec Dt:
01/17/2024
FERRO THERAPEUTICS, INC.
Exec Dt:
01/17/2024
SUB21, INC.
Exec Dt:
01/17/2024
Assignee:
BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
399 PARK AVENUE, 37TH FLOOR
NEW YORK, NEW YORK 10022
Correspondent:
COOLEY LLP
3 EMBARCADERO CENTER, 20TH FLOOR
SAN FRANCISCO, CA 94111
Assignment: 6
Reel/Frame:
066355/0126Recorded: 01/19/2024Pages: 29
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BRIDGEBIO PHARMA, INC.
Exec Dt:
01/17/2024
QED THERAPEUTICS, INC.
Exec Dt:
01/17/2024
EIDOS THERAPEUTICS, INC.
Exec Dt:
01/17/2024
THERAS, INC.
Exec Dt:
01/17/2024
ML BIO SOLUTIONS INC.
Exec Dt:
01/17/2024
CALCILYTIX THERAPEUTICS INC.
Exec Dt:
01/17/2024
ADRENAS THERAPEUTICS INC.
Exec Dt:
01/17/2024
PHOENIX TISSUE REPAIR, INC.
Exec Dt:
01/17/2024
NAVIRE PHARMA, INC.
Exec Dt:
01/17/2024
VENTHERA, INC.
Exec Dt:
01/17/2024
MOLECULAR SKIN THERAPEUTICS, INC.
Exec Dt:
01/17/2024
CANTERO THERAPEUTICS, INC.
Exec Dt:
01/17/2024
COA THERAPEUTICS, INC.
Exec Dt:
01/17/2024
PORTAL THERAPEUTICS, INC.
Exec Dt:
01/17/2024
BRIDGEBIO GENE THERAPY RESEARCH, INC.
Exec Dt:
01/17/2024
FERRO THERAPEUTICS, INC.
Exec Dt:
01/17/2024
SUB21, INC.
Exec Dt:
01/17/2024
Assignee:
BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
399 PARK AVENUE, 37TH FLOOR
NEW YORK, NEW YORK 10022
Correspondent:
COOLEY LLP
3 EMBARCADERO CENTER, 20TH FLOOR
SAN FRANCISCO, CA 94111

Search Results as of: 05/29/2024 07:07 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT